Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMD NASDAQ:FEMY NASDAQ:ICU NASDAQ:OSRH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.36-1.4%$2.16$1.31▼$27.40$3.27M1.491.70 million shs140,847 shsFEMYFemasys$4.01-1.7%$7.02$3.77▼$22.20$12.32M-2.2397,427 shs14,593 shsICUSeaStar Medical$3.44+6.2%$3.78$2.07▼$12.50$12.95M-1.0582,878 shs97,123 shsOSRHOSR$0.36-2.2%$0.51$0.36▼$1.57$12.96M0.611.02 million shs341,969 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical-1.45%-29.53%-38.18%-41.38%-90.29%FEMYFemasys-1.72%+4.43%-54.22%-60.90%-77.75%ICUSeaStar Medical+6.17%+13.16%-8.27%+50.88%+3.65%OSRHOSR-2.22%-3.35%-28.09%-17.95%-72.44%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.36-1.4%$2.16$1.31▼$27.40$3.27M1.491.70 million shs140,847 shsFEMYFemasys$4.01-1.7%$7.02$3.77▼$22.20$12.32M-2.2397,427 shs14,593 shsICUSeaStar Medical$3.44+6.2%$3.78$2.07▼$12.50$12.95M-1.0582,878 shs97,123 shsOSRHOSR$0.36-2.2%$0.51$0.36▼$1.57$12.96M0.611.02 million shs341,969 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical-1.45%-29.53%-38.18%-41.38%-90.29%FEMYFemasys-1.72%+4.43%-54.22%-60.90%-77.75%ICUSeaStar Medical+6.17%+13.16%-8.27%+50.88%+3.65%OSRHOSR-2.22%-3.35%-28.09%-17.95%-72.44%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 1.50ReduceN/AN/AFEMYFemasys 2.50Moderate Buy$106.672,560.02% UpsideICUSeaStar Medical 2.00Hold$8.00132.56% UpsideOSRHOSR 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest AEMD, OSRH, ICU, and FEMY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/18/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/14/2026ICUSeaStar Medical Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$6.00 ➝ $8.005/1/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/21/2026ICUSeaStar Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/20/2026AEMDAethlon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026OSRHOSR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon MedicalN/AN/AN/AN/A$3.11 per shareN/AFEMYFemasys$2.29M5.29N/AN/A$2.01 per share2.00ICUSeaStar Medical$1.23M11.19N/AN/A$2.75 per share1.25OSRHOSR$2.91M4.35N/AN/A$4.95 per share0.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$7.15M-$14.69N/AN/AN/AN/A-137.73%-105.87%8/12/2026 (Estimated)FEMYFemasys-$18.63M-$5.40N/AN/AN/A-521.97%-258.08%-73.72%8/12/2026 (Estimated)ICUSeaStar Medical-$12.15M-$4.80N/AN/AN/A-828.62%-146.29%-96.48%8/12/2026 (Estimated)OSRHOSR-$27.06M-$0.33N/AN/AN/A-363.26%-7.24%-5.41%N/ALatest AEMD, OSRH, ICU, and FEMY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026ICUSeaStar Medical-$0.8250-$0.90-$0.0750-$0.90$0.44 million$0.50 million5/13/2026Q1 2026OSRHOSRN/A-$0.09N/A-$0.0880N/A$0.48 million5/8/2026Q1 2026FEMYFemasys-$1.3334$0.0980+$1.4314N/A$0.77 million$0.42 million3/31/2026Q4 2025FEMYFemasys-$1.6666-$0.20+$1.4666-$0.01$1.06 million$0.81 million3/25/2026Q4 2025ICUSeaStar Medical-$0.97-$0.80+$0.17-$0.80$0.22 million$0.42 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/AFEMYFemasysN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A3.853.85FEMYFemasys0.533.911.98ICUSeaStar MedicalN/A2.732.71OSRHOSRN/A0.160.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%FEMYFemasys65.27%ICUSeaStar Medical1.69%OSRHOSR55.30%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical0.71%FEMYFemasys7.75%ICUSeaStar Medical0.70%OSRHOSR36.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.37 million2.35 millionNo DataFEMYFemasys303.02 million2.79 millionNot OptionableICUSeaStar Medical24.00 million3.97 millionNot OptionableOSRHOSRN/A35.10 million22.19 millionN/AAEMD, OSRH, ICU, and FEMY HeadlinesRecent News About These CompaniesOSR Holdings Is Now OSR Health - A New Name That Says Exactly What We DoJune 22 at 9:06 AM | accessnewswire.comAOSR Holdings Rebrands as OSR Health in Name ChangeJune 17, 2026 | tipranks.comCEO Statement to ShareholdersJune 3, 2026 | accessnewswire.comAOSR Holdings Secures VXM01 Rights in Asset DealJune 2, 2026 | tipranks.comOSR Holdings, Inc.: OSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million TransactionMay 28, 2026 | finanznachrichten.deOSR Holdings Acquires Full VXM01 Intellectual Property Portfolio in $30 Million TransactionMay 27, 2026 | accessnewswire.comAEmerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price TargetMay 5, 2026 | accessnewswire.comAOSR Holdings, Inc. Common Stock (OSRH) SEC FilingsMay 2, 2026 | nasdaq.comOSRH stock rockets 60% on $815M immunotherapy deal — retail bulls eye $1 mark for the stockApril 30, 2026 | msn.comOSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026April 30, 2026 | accessnewswire.comAOSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM EuropeApril 29, 2026 | accessnewswire.comAOSR Holdings Appoints New COO to Bolster Healthcare FocusApril 22, 2026 | tipranks.comOSR Holdings, Inc.: OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible NoteApril 10, 2026 | finanznachrichten.deOSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible NoteApril 9, 2026 | accessnewswire.comAOSR Holdings Revises Global License Deal for VXM01April 2, 2026 | tipranks.comOSR Holdings, Inc.: OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026March 31, 2026 | finanznachrichten.deOSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026March 30, 2026 | wfxg.comWEmerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price TargetMarch 27, 2026 | accessnewswire.comAOSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent LevelMarch 23, 2026 | accessnewswire.comAOSR Holdings, Inc.: Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial OpportunitiesMarch 19, 2026 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Case for Intel Over Pure-Play Quantum FirmsBy Nathan Reiff | June 9, 2026Why 1 Little-Known ETF Is Riding the AI Chip ShortageBy Nathan Reiff | June 2, 2026Is Lennar Finally Turning the Corner After Its Housing Slump?By Leo Miller | June 16, 2026AEMD, OSRH, ICU, and FEMY Company DescriptionsAethlon Medical NASDAQ:AEMD$1.36 -0.02 (-1.45%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$1.45 +0.09 (+6.47%) As of 08:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Femasys NASDAQ:FEMY$4.01 -0.07 (-1.72%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$4.20 +0.19 (+4.64%) As of 09:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.SeaStar Medical NASDAQ:ICU$3.44 +0.20 (+6.17%) Closing price 06/23/2026 03:54 PM EasternExtended Trading$3.46 +0.02 (+0.44%) As of 08:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.OSR NASDAQ:OSRH$0.36 -0.01 (-2.22%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$0.36 +0.00 (+0.28%) As of 08:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning Why nVent Could Be a Long-Term AI Infrastructure Winner These AI Stocks Have Insider Selling, But Buyers Still Have a Reason to Stay Apple’s Intel Deal Arrives at the Right Time for Its Stock Micron’s Sudden Plunge May Be an AI Buying Chance Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. How Does D-Wave's New Simulator Change the Quantum Computing Landscape? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
